APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Consortium

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medical Consortium Market Analysis and Forecast 2026-2032

28 December 2025197 pages

Choose your research edition.

Industry ResearchMedical Consortium Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Consortium Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Consortium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Consortium Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Consortium Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medical Consortium market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Consortium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Consortium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Consortium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Consortium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Consortium include Epic Systems Corporation, Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Siemens Healthineers, Athenahealth, GE Healthcare, Philips Healthcare and IBM Watson Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Consortium, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Consortium, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Consortium, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Consortium revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Consortium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Consortium revenue, projected growth trends, production technology, application and end-user industry.

Medical Consortium Segment by Company

Epic Systems Corporation

Cerner Corporation

McKesson Corporation

Allscripts Healthcare Solutions

Siemens Healthineers

Athenahealth

GE Healthcare

Philips Healthcare

IBM Watson Health

Oracle Corporation

Agfa-Gevaert Group

Fujifilm Holdings Corporation

Medical Consortium Segment by Type

Clinical Integrated

Financial Integration Type

Information Integration Type

Medical Consortium Segment by Application

Patient Care Collaboration

Resource Sharing

Disease Management

Medical Consortium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Consortium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Consortium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Consortium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Consortium in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Consortium company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Consortium revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Consortium Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Clinical Integrated Major Player Table 3. Financial Integration Type Major Player Table 4. Information Integration Type Major Player Table 5. Global Medical Consortium Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Patient Care Collaboration Major Player Table 7. Resource Sharing Major Player Table 8. Disease Management Major Player Table 9. Medical Consortium Industry Trends Table 10. Medical Consortium Industry Drivers Table 11. Medical Consortium Industry Opportunities and Challenges Table 12. Medical Consortium Industry Restraints Table 13. Global Medical Consortium Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Medical Consortium Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Medical Consortium Market Share by Region (2021-2026) Table 16. Global Medical Consortium Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Medical Consortium Market Share by Region (2027-2032) Table 18. Global Medical Consortium Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Medical Consortium Revenue Market Share by Players (2021-2026) Table 20. Global Medical Consortium Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Medical Consortium Key Players Headquarters & Area Served Table 22. Global Medical Consortium Players, Product Type & Application Table 23. Global Medical Consortium Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Medical Consortium by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Medical Consortium Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Consortium Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Medical Consortium Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Medical Consortium Revenue Market Share by Type (2021-2026) Table 30. Global Medical Consortium Revenue Market Share by Type (2027-2032) Table 31. Global Medical Consortium Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Consortium Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Medical Consortium Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Medical Consortium Revenue Market Share by Application (2021-2026) Table 35. Global Medical Consortium Revenue Market Share by Application (2027-2032) Table 36. Epic Systems Corporation Company Information Table 37. Epic Systems Corporation Business Overview Table 38. Epic Systems Corporation Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Epic Systems Corporation Medical Consortium Product Portfolio Table 40. Epic Systems Corporation Recent Development Table 41. Cerner Corporation Company Information Table 42. Cerner Corporation Business Overview Table 43. Cerner Corporation Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Cerner Corporation Medical Consortium Product Portfolio Table 45. Cerner Corporation Recent Development Table 46. McKesson Corporation Company Information Table 47. McKesson Corporation Business Overview Table 48. McKesson Corporation Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. McKesson Corporation Medical Consortium Product Portfolio Table 50. McKesson Corporation Recent Development Table 51. Allscripts Healthcare Solutions Company Information Table 52. Allscripts Healthcare Solutions Business Overview Table 53. Allscripts Healthcare Solutions Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Allscripts Healthcare Solutions Medical Consortium Product Portfolio Table 55. Allscripts Healthcare Solutions Recent Development Table 56. Siemens Healthineers Company Information Table 57. Siemens Healthineers Business Overview Table 58. Siemens Healthineers Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Siemens Healthineers Medical Consortium Product Portfolio Table 60. Siemens Healthineers Recent Development Table 61. Athenahealth Company Information Table 62. Athenahealth Business Overview Table 63. Athenahealth Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Athenahealth Medical Consortium Product Portfolio Table 65. Athenahealth Recent Development Table 66. GE Healthcare Company Information Table 67. GE Healthcare Business Overview Table 68. GE Healthcare Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GE Healthcare Medical Consortium Product Portfolio Table 70. GE Healthcare Recent Development Table 71. Philips Healthcare Company Information Table 72. Philips Healthcare Business Overview Table 73. Philips Healthcare Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Philips Healthcare Medical Consortium Product Portfolio Table 75. Philips Healthcare Recent Development Table 76. IBM Watson Health Company Information Table 77. IBM Watson Health Business Overview Table 78. IBM Watson Health Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. IBM Watson Health Medical Consortium Product Portfolio Table 80. IBM Watson Health Recent Development Table 81. Oracle Corporation Company Information Table 82. Oracle Corporation Business Overview Table 83. Oracle Corporation Medical Consortium Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Oracle Corporation Medical Consortium Product Portfolio Table 85. Oracle Corporation Recent Development Table 86. Agfa-Gevaert Group Company Information Table 87. Agfa-Gevaert Group Business Overview Table 88. Agfa-Gevaert Group Medical Consortium Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Agfa-Gevaert Group Medical Consortium Product Portfolio Table 90. Agfa-Gevaert Group Recent Development Table 91. Fujifilm Holdings Corporation Company Information Table 92. Fujifilm Holdings Corporation Business Overview Table 93. Fujifilm Holdings Corporation Medical Consortium Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Fujifilm Holdings Corporation Medical Consortium Product Portfolio Table 95. Fujifilm Holdings Corporation Recent Development Table 96. North America Medical Consortium Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Medical Consortium Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Medical Consortium Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Medical Consortium Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Medical Consortium Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Medical Consortium Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Medical Consortium Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Medical Consortium Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Medical Consortium Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Medical Consortium Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Medical Consortium Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Medical Consortium Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Medical Consortium Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Medical Consortium Revenue by Country (US$ Million) & (2027-2032) Table 110. China Medical Consortium Revenue by Type (2021-2026) & (US$ Million) Table 111. China Medical Consortium Revenue by Type (2027-2032) & (US$ Million) Table 112. China Medical Consortium Revenue by Application (2021-2026) & (US$ Million) Table 113. China Medical Consortium Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Medical Consortium Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Medical Consortium Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Medical Consortium Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Medical Consortium Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Medical Consortium Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Medical Consortium Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Medical Consortium Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Medical Consortium Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Medical Consortium Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Medical Consortium Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Medical Consortium Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Medical Consortium Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Medical Consortium Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Medical Consortium Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Medical Consortium Image Figure 2. Global Medical Consortium Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Consortium Market Size Share 2021 VS 2025 VS 2032 Figure 4. Clinical Integrated Image Figure 5. Financial Integration Type Image Figure 6. Information Integration Type Image Figure 7. Global Medical Consortium Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Medical Consortium Market Size Share 2021 VS 2025 VS 2032 Figure 9. Patient Care Collaboration Image Figure 10. Resource Sharing Image Figure 11. Disease Management Image Figure 12. Global Medical Consortium Market Size (US$ Million) & (2021-2032) Figure 13. Global Medical Consortium Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Medical Consortium Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Medical Consortium Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Medical Consortium Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Consortium Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Consortium Revenue Market Share by Type (2021-2032) Figure 20. Global Medical Consortium Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medical Consortium Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Medical Consortium Revenue Market Share by Application (2021-2032) Figure 23. North America Medical Consortium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Medical Consortium Revenue Share by Type (2021-2032) Figure 25. North America Medical Consortium Revenue Share by Application (2021-2032) Figure 26. North America Medical Consortium Revenue Share by Country (2021-2032) Figure 27. United States Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Medical Consortium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Medical Consortium Revenue Share by Type (2021-2032) Figure 32. Europe Medical Consortium Revenue Share by Application (2021-2032) Figure 33. Europe Medical Consortium Revenue Share by Country (2021-2032) Figure 34. Germany Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Medical Consortium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Medical Consortium Revenue Share by Type (2021-2032) Figure 44. China Medical Consortium Revenue Share by Application (2021-2032) Figure 45. Asia Medical Consortium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Medical Consortium Revenue Share by Type (2021-2032) Figure 47. Asia Medical Consortium Revenue Share by Application (2021-2032) Figure 48. Asia Medical Consortium Revenue Share by Region (2021-2032) Figure 49. Japan Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Medical Consortium Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Medical Consortium Revenue Share by Type (2021-2032) Figure 57. SAMEA Medical Consortium Revenue Share by Application (2021-2032) Figure 58. SAMEA Medical Consortium Revenue Share by Country (2021-2032) Figure 59. Brazil Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Medical Consortium Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Integrated
  • Financial Integration Type
  • Information Integration Type
Applications
  • Patient Care Collaboration
  • Resource Sharing
  • Disease Management
Companies covered
  • Epic Systems Corporation
  • Cerner Corporation
  • McKesson Corporation
  • Allscripts Healthcare Solutions
  • Siemens Healthineers
  • Athenahealth
  • GE Healthcare
  • Philips Healthcare
  • IBM Watson Health
  • Oracle Corporation
  • Agfa-Gevaert Group
  • Fujifilm Holdings Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Consortium Market by Type
  3. 1.2.1 Global Medical Consortium Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Clinical Integrated
  5. 1.2.3 Financial Integration Type
  6. 1.2.4 Information Integration Type
  7. 1.3 Medical Consortium Market by Application
  8. 1.3.1 Global Medical Consortium Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Patient Care Collaboration
  10. 1.3.3 Resource Sharing
  11. 1.3.4 Disease Management
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Medical Consortium Market Dynamics
  1. 2.1 Medical Consortium Industry Trends
  2. 2.2 Medical Consortium Industry Drivers
  3. 2.3 Medical Consortium Industry Opportunities and Challenges
  4. 2.4 Medical Consortium Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Consortium Market Perspective (2021-2032)
  2. 3.2 Global Medical Consortium Growth Trends by Region
  3. 3.2.1 Global Medical Consortium Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Consortium Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Consortium Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Consortium Revenue by Players
  2. 4.1.1 Global Medical Consortium Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Consortium Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Consortium Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Consortium Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Consortium Key Players Headquarters & Area Served
  7. 4.4 Global Medical Consortium Players, Product Type & Application
  8. 4.5 Global Medical Consortium Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Consortium Market CR5 and HHI
  11. 4.6.3 2025 Medical Consortium Tier 1, Tier 2, and Tier 3
5 Medical Consortium Market Size by Type
  1. 5.1 Global Medical Consortium Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Consortium Revenue by Type (2021-2032)
  3. 5.3 Global Medical Consortium Revenue Market Share by Type (2021-2032)
6 Medical Consortium Market Size by Application
  1. 6.1 Global Medical Consortium Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Consortium Revenue by Application (2021-2032)
  3. 6.3 Global Medical Consortium Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Epic Systems Corporation
  2. 7.1.1 Epic Systems Corporation Company Information
  3. 7.1.2 Epic Systems Corporation Business Overview
  4. 7.1.3 Epic Systems Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Epic Systems Corporation Medical Consortium Product Portfolio
  6. 7.1.5 Epic Systems Corporation Recent Developments
  7. 7.2 Cerner Corporation
  8. 7.2.1 Cerner Corporation Company Information
  9. 7.2.2 Cerner Corporation Business Overview
  10. 7.2.3 Cerner Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cerner Corporation Medical Consortium Product Portfolio
  12. 7.2.5 Cerner Corporation Recent Developments
  13. 7.3 McKesson Corporation
  14. 7.3.1 McKesson Corporation Company Information
  15. 7.3.2 McKesson Corporation Business Overview
  16. 7.3.3 McKesson Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  17. 7.3.4 McKesson Corporation Medical Consortium Product Portfolio
  18. 7.3.5 McKesson Corporation Recent Developments
  19. 7.4 Allscripts Healthcare Solutions
  20. 7.4.1 Allscripts Healthcare Solutions Company Information
  21. 7.4.2 Allscripts Healthcare Solutions Business Overview
  22. 7.4.3 Allscripts Healthcare Solutions Medical Consortium Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Allscripts Healthcare Solutions Medical Consortium Product Portfolio
  24. 7.4.5 Allscripts Healthcare Solutions Recent Developments
  25. 7.5 Siemens Healthineers
  26. 7.5.1 Siemens Healthineers Company Information
  27. 7.5.2 Siemens Healthineers Business Overview
  28. 7.5.3 Siemens Healthineers Medical Consortium Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Siemens Healthineers Medical Consortium Product Portfolio
  30. 7.5.5 Siemens Healthineers Recent Developments
  31. 7.6 Athenahealth
  32. 7.6.1 Athenahealth Company Information
  33. 7.6.2 Athenahealth Business Overview
  34. 7.6.3 Athenahealth Medical Consortium Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Athenahealth Medical Consortium Product Portfolio
  36. 7.6.5 Athenahealth Recent Developments
  37. 7.7 GE Healthcare
  38. 7.7.1 GE Healthcare Company Information
  39. 7.7.2 GE Healthcare Business Overview
  40. 7.7.3 GE Healthcare Medical Consortium Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GE Healthcare Medical Consortium Product Portfolio
  42. 7.7.5 GE Healthcare Recent Developments
  43. 7.8 Philips Healthcare
  44. 7.8.1 Philips Healthcare Company Information
  45. 7.8.2 Philips Healthcare Business Overview
  46. 7.8.3 Philips Healthcare Medical Consortium Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Philips Healthcare Medical Consortium Product Portfolio
  48. 7.8.5 Philips Healthcare Recent Developments
  49. 7.9 IBM Watson Health
  50. 7.9.1 IBM Watson Health Company Information
  51. 7.9.2 IBM Watson Health Business Overview
  52. 7.9.3 IBM Watson Health Medical Consortium Revenue and Gross Margin (2021-2026)
  53. 7.9.4 IBM Watson Health Medical Consortium Product Portfolio
  54. 7.9.5 IBM Watson Health Recent Developments
  55. 7.10 Oracle Corporation
  56. 7.10.1 Oracle Corporation Company Information
  57. 7.10.2 Oracle Corporation Business Overview
  58. 7.10.3 Oracle Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Oracle Corporation Medical Consortium Product Portfolio
  60. 7.10.5 Oracle Corporation Recent Developments
  61. 7.11 Agfa-Gevaert Group
  62. 7.11.1 Agfa-Gevaert Group Company Information
  63. 7.11.2 Agfa-Gevaert Group Business Overview
  64. 7.11.3 Agfa-Gevaert Group Medical Consortium Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Agfa-Gevaert Group Medical Consortium Product Portfolio
  66. 7.11.5 Agfa-Gevaert Group Recent Developments
  67. 7.12 Fujifilm Holdings Corporation
  68. 7.12.1 Fujifilm Holdings Corporation Company Information
  69. 7.12.2 Fujifilm Holdings Corporation Business Overview
  70. 7.12.3 Fujifilm Holdings Corporation Medical Consortium Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Fujifilm Holdings Corporation Medical Consortium Product Portfolio
  72. 7.12.5 Fujifilm Holdings Corporation Recent Developments
8 North America
  1. 8.1 North America Medical Consortium Revenue (2021-2032)
  2. 8.2 North America Medical Consortium Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Consortium Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Consortium Revenue by Type (2027-2032)
  5. 8.3 North America Medical Consortium Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Consortium Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Consortium Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Consortium Revenue by Application (2027-2032)
  9. 8.5 North America Medical Consortium Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Consortium Revenue by Country
  11. 8.6.1 North America Medical Consortium Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Consortium Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Consortium Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Consortium Revenue (2021-2032)
  2. 9.2 Europe Medical Consortium Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Consortium Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Consortium Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Consortium Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Consortium Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Consortium Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Consortium Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Consortium Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Consortium Revenue by Country
  11. 9.6.1 Europe Medical Consortium Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Consortium Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Consortium Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Consortium Revenue (2021-2032)
  2. 10.2 China Medical Consortium Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Consortium Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Consortium Revenue by Type (2027-2032)
  5. 10.3 China Medical Consortium Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Consortium Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Consortium Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Consortium Revenue by Application (2027-2032)
  9. 10.5 China Medical Consortium Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Consortium Revenue (2021-2032)
  2. 11.2 Asia Medical Consortium Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Consortium Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Consortium Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Consortium Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Consortium Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Consortium Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Consortium Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Consortium Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Consortium Revenue by Country
  11. 11.6.1 Asia Medical Consortium Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Consortium Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Consortium Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Consortium Revenue (2021-2032)
  2. 12.2 SAMEA Medical Consortium Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Consortium Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Consortium Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Consortium Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Consortium Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Consortium Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Consortium Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Consortium Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Consortium Revenue by Country
  11. 12.6.1 SAMEA Medical Consortium Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Consortium Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Consortium Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst